Credit Suisse’s Axonics, Inc. Common Stock AXNX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXNX
UOC
AAM
MF
Credit Suisse's AXNX Position: Q1 2024 in Review
Credit Suisse reduced its Axonics, Inc. Common Stock (AXNX) stake by 90% in Q1 2024, selling an estimated $59.7M and leaving 99,555 shares worth $6.87M. The position accounts for 0.01% of the portfolio, ranked #1118.
Credit Suisse first reported a position in AXNX in Q2 2019 and has held it in 19 quarters since. The position peaked at $165M in Q2 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.
- Credit Suisse held 99,555 shares of Axonics, Inc. Common Stock worth $6.87M as of Q1 2024.
- Credit Suisse sold 884,505 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $59.7M.
- Axonics, Inc. Common Stock made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1118 holding.
- Credit Suisse first reported a position in Axonics, Inc. Common Stock in Q2 2019 and has held it in 19 quarters since.
- Credit Suisse's Axonics, Inc. Common Stock position peaked at $165M in Q2 2021.
- 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.